BrightPath Biotherapeutics Co.,Ltd.

4594

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2027 Q1

Revenue

62,000JPY

YoY -94.6%

Operating Income

-5.5100M JPY

YoY -123.0%

Net Income

-15.9100M JPY

YoY -50.0%

EPS

-3.8JPY

YoY -47.5%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

15.4百万円

-3.6億円

-7.4億円

-11.1億円

-14.9億円

Rev: 15.4百万円Op: -14.8億円NI: -14.8億円

Rev: 5.3百万円Op: -14.7億円NI: -14.9億円

Rev: 72,000Op: -11.6億円NI: -11.7億円

Rev: 1.1百万円Op: -11.6億円NI: -11.5億円

Rev: 84,000Op: -13億円NI: -13億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress0

Revenue Forecast0

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan